SCHEMBL20313679

SCHEMBL20313679

C=C(CN(C)C)C(=O)OCCOc1ccc(-c2ccc(-c3ccc(OCCOC(=O)C(=C)CN(C)C)cc3)c(CCCCCC)c2)cc1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ RARB P10826 5/20 0.41
▸ PTPN11 Q06124 2/20 0.41
▸ MEN1 O00255 1/20 0.40
▸ USP2 O75604 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ CASP1 P29466 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ SLCO1B3 Q9NPD5 1/20 0.40
▸ SLCO1B1 Q9Y6L6 1/20 0.40
▸ THRA P10827 1/20 0.39
▸ THRB P10828 1/20 0.39
▸ RARA P10276 1/20 0.39
▸ CNR2 P34972 6/20 0.37
▸ CNR1 P21554 1/20 0.37
▸ PLA2G4A P47712 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19855276 0.90 RARB (0.44) RARBPTPN11MEN1USP2ALDH1A1
SCHEMBL19854384 0.90 RARB (0.44) RARBPTPN11MEN1USP2ALDH1A1
SCHEMBL20313677 0.89 RARB (0.44) RARBPTPN11MEN1USP2ALDH1A1
SCHEMBL19722626 0.88 MEN1 (0.42) RARBPTPN11MEN1USP2ALDH1A1
SCHEMBL19854461 0.87 RARB (0.45) RARBPTPN11MEN1USP2ALDH1A1
SCHEMBL20313678 0.86 RARB (0.40) RARBPTPN11MEN1USP2ALDH1A1
SCHEMBL20407720 0.85 NR5A1 (0.43) RARBPTPN11RARACNR2CNR1
SCHEMBL19854167 0.85 RARB (0.41) RARBPTPN11MEN1USP2ALDH1A1
SCHEMBL20313680 0.85 RARB (0.41) RARBPTPN11MEN1USP2ALDH1A1
SCHEMBL19722628 0.85 MEN1 (0.49) RARBMEN1USP2ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210214615-A1 LIQUID CRYSTAL DISPLAY DEVICE AND DISPLAY UNIT JNC CORPORATION (JP) 2021-07-15 — — US disclosed
US-20180179443-A1 POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2018-06-28 — — US disclosed
US-20180179443-A1 POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2018-06-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180179443-A1 POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE C1S, CCND1, C5 RARB 3791/4885PTPN11 3649/4885MEN1 980/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback